Theravance Biopharma Inc (TBPH) Actualités

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results

Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results PR...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire DUBLIN, Feb. 20, 2025...

Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 PR...

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire DUBLIN, Feb. 5, 2025...

Form 4 - Statement of changes in beneficial ownership of securities